R&D, Reimbursement Impact Of Device Trial Data Bank Sought By FDA
This article was originally published in The Gray Sheet
Executive Summary
FDA is seeking industry input on the potential impact on future R&D efforts of mandatory disclosure of device clinical trial data in a public database managed by the National Institutes of Health.